Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

Clinical trial NCT07256210 · RECRUITING

Trial details

NCT number: NCT07256210
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic T-cell Leukemia Mixed Phenotype Acute Leukemia

Start date: 2025-05-09
Primary completion: 2026-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.